Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
19,319
Total Claims
$1.5M
Drug Cost
648
Beneficiaries
$2,309
Cost/Patient
Risk Score Breakdown 15/100
Score components are additive. Read full methodology
Peer Comparison vs. 1,825 Geriatric Medicine providers
-84%
Opioid rate vs peers
0.4% vs 2.6% avg
+87%
Cost per patient vs peers
$2,309 vs $1,237 avg
+111%
Brand preference vs peers
19.3% vs 9.2% avg
Opioid Prescribing
0.4%
Opioid Rate
77
Opioid Claims
$2,624
Opioid Cost
16.9%
Long-Acting Rate
Brand vs Generic
Brand: 3,720 claims · $996K
Generic: 15,529 claims · $497K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Apixaban | 882 | $235K |
| Paliperidone Palmitate | 26 | $89K |
| Rifaximin | 52 | $56K |
| Dulaglutide | 68 | $34K |
| Carbidopa/Levodopa | 56 | $33K |
| Sitagliptin Phosphate | 94 | $30K |
| Mirabegron | 87 | $23K |
| Tiotropium Bromide | 42 | $23K |
| Pimavanserin Tartrate | 11 | $23K |
| Insulin Glargine,hum.Rec.Anlog | 179 | $22K |
| Ertapenem Sodium | 54 | $20K |
| Atorvastatin Calcium | 1,245 | $16K |
| Sevelamer Hcl | 18 | $16K |
| Rivaroxaban | 64 | $16K |
| Budesonide | 78 | $16K |
Prescribing Profile
Patient Profile
74
Avg Age
57%
Female
2.50
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations of wrongdoing.Methodology · About · Dispute this data